Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 18, 2023 - Issue
Submit an article Journal homepage
446
Views
7
CrossRef citations to date
0
Altmetric
REVIEW

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease

Wenwen Wang1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Aihua Mei1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Hang Qian1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Dongfeng Li1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Hao Xu1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Jishun Chen1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Handong Yang1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Xinwen Min1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Chunlei Li1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
,
Li Cheng1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of ChinaView further author information
&
Jun Chen1 Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine), Shiyan, People’s Republic of China;2 Institute of Virology, Hubei University of Medicine, Shiyan, Hubei, 442000, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-9071-2436View further author information
ORCID Icon show all
Pages 129-137 | Received 13 Oct 2022, Accepted 02 Feb 2023, Published online: 15 Feb 2023

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Joshua Reed, Stephen C Bain & Venkateswarlu Kanamarlapudi. (2024) The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets. Diabetes, Metabolic Syndrome and Obesity 17, pages 2419-2456.
Read now

Articles from other publishers (6)

Shahad Sabaawi Ibrahim, Raghad Sabaawi Ibrahim, Batoul Arabi, Aranka Brockmueller, Mehdi Shakibaei & Dietrich Büsselberg. (2024) The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer. Cancer and Metastasis Reviews.
Crossref
Yue Su, Youqian Zhang & Jinfu Xu. (2024) Genetic variations in anti-diabetic drug targets and COPD risk: evidence from mendelian randomization. BMC Pulmonary Medicine 24:1.
Crossref
Tianyu Wang, Juncan Ding, Xinyi Cheng, Qiang Yang & Pengfei Hu. (2024) Glucagon-like peptide-1 receptor agonists: new strategies and therapeutic targets to treat atherosclerotic cardiovascular disease. Frontiers in Pharmacology 15.
Crossref
Bente Brauwers, Felipe V. C. Machado, Rosanne J. H. C. G. Beijers, Martijn A. Spruit & Frits M. E. Franssen. (2023) Combined Exercise Training and Nutritional Interventions or Pharmacological Treatments to Improve Exercise Capacity and Body Composition in Chronic Obstructive Pulmonary Disease: A Narrative Review. Nutrients 15:24, pages 5136.
Crossref
Dinah Foer, Zachary H. Strasser, Jing Cui, Katherine N. Cahill, Joshua A. Boyce, Shawn N. Murphy & Elizabeth W. Karlson. (2023) Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes. American Journal of Respiratory and Critical Care Medicine 208:10, pages 1088-1100.
Crossref
Mario Cazzola, Paola Rogliani, Josuel Ora, Luigino Calzetta, Davide Lauro & Maria Gabriella Matera. (2023) Hyperglycaemia and Chronic Obstructive Pulmonary Disease. Diagnostics 13:21, pages 3362.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.